The era of high profits in the caprolactam industry may be far away 2020-01-17
Source: China Chemical News Time: 2020-01-17 In the past 2019, the former star product caprolactam walked down the altar and was trapped in a loss. This cannot help but sigh, the era of high profits in the caprolactam industry may be far away. The author believes that there are three main reasons for the deep loss of the caprolactam industry: First, the pressure of excess capacity is manifesting. In 2019, the original domestic production capacity of caprolactam was 1.23 million tons/year. However, in view of the unsatisfactory market situation, many companies have postponed the commissioning schedule. During the year, only Fujian Jinjiang Technology's 200,000 tons/year device was put into production. The average load is currently about 80%, and Hebei Xuyang's 100,000 tons/year device is expanded to 150,000 tons/year, Baling Hengyi added 100,000 tons/year capacity device. In addition, due to the restrictions of domestic environmental protection and safety policies, the operation of some enterprises has been greatly affected. For example, Jiangsu Haili’s 200,000 tons/year device was installed in 2019.
Read More